| May 31 |
Citi downgrades Calliditas to neutral, cites takeover offer
|
| May 31 |
Swedish Growth Companies With High Insider Ownership Spotlight May 2024
|
| May 30 |
Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathy
|
| May 29 |
Swedish Exchange Highlights: 3 Growth Companies With High Insider Ownership
|
| May 29 |
Swedish Exchange Growth Leaders: 3 Companies With Significant Insider Ownership
|
| May 28 |
Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics
|
| May 28 |
Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress
|
| May 28 |
Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn
|
| May 28 |
Asahi Kasei offers to buy Calliditas Therapeutics for $1.1B
|
| May 28 |
Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
|
